Japanese multinational pharmaceutical company, with American and British roots, Takeda, is holding talks with India’s medicine regulator, the Drug Controller General of India (DCGI), for bringing its dengue vaccine to the country. Mahender Nayak, head of Asia Pacific, Takeda Pharmaceuticals, said that the company was discussing terms of regulatory approval...